Recently, House Democrats put forth a bill that would allow Medicare to leverage its size and scale to negotiate lower drug prices with pharma companies. It's estimated that the approach would save the U. The bill hit a roadblock after a few moderate Democrats and many Republicans voted in opposition. Thus, it appears that the odds of passing the House and Senate to make it to the desk of the White House for enactment are rather low. And since the U. The first cushion for the business is that For context, U.
Food and Drug Administration FDA in , which should translate into revenue growth for the drug this decade and into the beginning of next decade. Tremfya alone should be able to offset much of Stelara's post-patent cliff revenue declines. A market-beating 2. Discounted offers are only available to new members.
Stock Advisor will renew at the then current list price. Average returns of all recommendations since inception. A positive change in the cash flow is desired and shows that more 'cash' is coming in than 'cash' going out. The Historical Cash Flow Growth is the longer-term year annualized growth rate of the cash flow change. Once again, cash flow is net income plus depreciation and other non-cash charges.
Cash flow itself is an important item on the income statement. While the one year change shows the current conditions, the longer look-back period shows how this metric has changed over time and helps put the current reading into proper perspective. Also, by looking at the rate of this item, rather than the actual dollar value, it makes for easier comparisons across the industry and peers.
The Current Ratio is defined as current assets divided by current liabilities. It measures a company's ability to pay short-term obligations. It's also commonly referred to as a 'liquidity ratio'. A ratio of 1 means a company's assets are equal to its liabilities.
Less than 1 means its liabilities exceed its short-term assets cash, inventory, receivables, etc. Above 1 means it assets are greater than its liabilities. A ratio of 2 means its assets are twice that of its liabilities. A higher number is better than a lower number. A 'good' number would usually fall within the range of 1. Like most ratios, this number will vary from industry to industry. This measure is expressed as a percentage.
A higher number means the more debt a company has compared to its capital structure. Investors like this metric as it shows how a company finances its operations, i. But note; this ratio can vary widely from industry to industry.
So be sure to compare it to its group when comparing stocks in different industries. Net Margin is defined as net income divided by sales. This shows the percentage of profit a company earns on its sales. A change in margin can reflect either a change in business conditions, or a company's cost controls, or both.
If a company's expenses are growing faster than their sales, this will reduce their margins. But note, different industries have different margin rates that are considered good. And margin rates can vary significantly across these different groups.
So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. Return on Equity or ROE is calculated as income divided by average shareholder equity past 12 months, including reinvested earnings. The income number is listed on a company's Income Statement.
ROE is always expressed as a percentage. Seeing how a company makes use of its equity, and the return generated on it, is an important measure to look at. ROE values, like other values, can vary significantly from one industry to another. As the name suggests, it's calculated as sales divided by assets. This is also commonly referred to as the Asset Utilization ratio.
A higher number is better than a lower one as it shows how effective a company is at generating revenue from its assets. It takes the consensus sales estimate for the current fiscal year F1 divided by the sales for the last completed fiscal year F0 actual if reported, the consensus if not.
While earnings are the driving metric behind stock prices, there wouldn't be any earnings to calculate if there weren't any sales to begin with. Like earnings, a higher growth rate is better than a lower growth rate. Seeing a company's projected sales growth instantly tells you what the outlook is for their products and services.
Of course, different industries will have different growth rates that are considered good. So be sure to compare a stock to its industry's growth rate when sizing up stocks from different groups. The Daily Price Change displays the day's percentage price change using the most recently completed close.
This item is updated at 9 pm EST each day. While the hover-quote on Zacks. This is useful for obvious reasons, but can also put the current day's intraday gains into better context by knowing if the recently completed trading day was up or down.
The 1 Week Price Change displays the percentage price change over the last 5 trading days using the most recently completed close to the close from 5 days before. The 1 week price change reflects the collective buying and selling sentiment over the short-term.
A strong weekly advance especially when accompanied by increased volume is a sought after metric for putting potential momentum stocks onto one's radar. Others will look for a pullback on the week as a good entry point, assuming the longer-term price changes 4 week, 12 weeks, etc. The Momentum Score takes all of this and more into account. The 4 Week Price Change displays the percentage price change for the most recently completed 4 weeks 20 trading days.
This is a medium-term price change metric. The 4 week price change is a good reference point for the individual stock and how it's performed in relation to its peers. The 12 Week Price Change displays the percentage price change over the most recently completed 12 weeks 60 days. This is a medium-term price change metric like the 4 week price change. With 12 weeks representing a meaningful part of a year, this time period will show whether a stock has been enjoying strong investor demand, or if it's in consolidation, or distress.
The 52 Week Price Change displays the percentage price change over the most recently completed 52 weeks trading days. This is a longer-term price change metric. The 52 week price change is a good reference point. Some investors seek out stocks with the best percentage price change over the last 52 weeks, expecting that momentum to continue.
Others look for those that have lagged the market, believing those are the ones ripe for the biggest increases to come.
Regardless of the many ways investors use this item, whether looking at a stock's price change, an index's return, or a portfolio manager's performance, this time-frame is a common judging metric in the financial industry.
The 20 Day Average Volume is the average daily trading volume over the last 20 trading days. Volume is a useful item in many ways.
For one, part of trading is being able to get in and out of a stock easily. Rachel Warren : So another great healthcare stock that I write about often. For me, like with these other big pharma companies. It's been around for about a years now. And, it's not one of those companies that is going to supercharge your portfolio overnight. But the thing that I love about it, and I think a lot of investors do, is it delivers that slow and steady and consistent growth in a variety of markets. It's one that you can really depend on for that.
It does also pay a nice dividend, and it qualifies as a Dividend King, because it has consecutively every year raising its dividend for more than 50 years. It's current dividend is about 2. You've got those brands that everyone has in their house: Johnson's, Aveeno, Tylenol, Motrin. But I think that's actually something that's a big draw for a company if you look at it as a potential investor from the perspective of a consumer.
You know, is this a company that like people use their products daily, are their products consistently in demand? That can be a really good indicator of whether a company is going to have real staying power in your portfolio. The company has not generally reported super-high annual earnings growth.
Generally it's more of those slow, steady growth returns.
0コメント